{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T05:18:41Z","timestamp":1787635121662,"version":"build-2736575974"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>While systemic inflammation (hs-CRP) is linked to intracranial atherosclerosis, how it precisely translates into focal posterior circulation infarction (PCI) remains elusive. Previous studies largely treat inflammation and hemodynamics as isolated risk factors, leaving their potential synergistic mechanisms unquantified. We hypothesized that vertebral artery volume flow (VAVF) may partly account for the observed association between hs-CRP and PCI, thereby exploring a potential inflammatory-hemodynamic interaction in severe intracranial vertebral artery stenosis (IVAS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective cohort study included 253 consecutive patients with newly diagnosed severe IVAS. We assessed baseline hs-CRP, VAVF, and incident PCI using generalized additive models, exploratory mediation analysis, and network analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      During follow-up, 96 patients (37.9%) developed PCI. Each 1-mg\/L increase in hs-CRP was associated with higher odds of PCI (adjusted OR, 1.26; 95% CI, 1.15\u20131.38;\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.001). The association was nonlinear, with an inflection point at 5.67\u202fmg\/L and a plateau above 13.28\u202fmg\/L. Network analysis identified hs-CRP as a central node within the biomarker network. Exploratory mediation analysis suggested that VAVF partly accounted for the association, with an estimated proportion mediated of 13.2% (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.002). The association was strongest in the lowest VAVF tertile.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings support a potential inflammatory-hemodynamic interaction where systemic inflammation is associated with impaired local perfusion and increased risk of PCI. Identification of this \u201clow-flow, high-inflammation\u201d phenotype may provide a framework for future risk stratification and prospective evaluation of inflammation-targeted strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneur.2026.1829231","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T04:23:08Z","timestamp":1787631788000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Inflammatory-hemodynamic interplay in severe intracranial stenosis: hs-CRP, vertebral artery flow, and posterior circulation infarction"],"prefix":"10.3389","volume":"17","author":[{"given":"Xiaofeng","family":"Yuan","sequence":"first","affiliation":[{"name":"Kunshan Clinical Innovation Research Center of Nantong University","place":["Kunshan, Jiangsu, China"]},{"name":"Department of Stroke Center, The First People's Hospital of Kunshan","place":["Kunshan, Jiangsu, China"]},{"name":"Department of Ultrasound, The First People's Hospital of Kunshan","place":["Kunshan, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Kunshan Clinical Innovation Research Center of Nantong University","place":["Kunshan, Jiangsu, China"]},{"name":"Department of Stroke Center, The First People's Hospital of Kunshan","place":["Kunshan, Jiangsu, China"]},{"name":"Department of Neurology, The First People's Hospital of Kunshan","place":["Kunshan, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Ma","sequence":"additional","affiliation":[{"name":"Kunshan Clinical Innovation Research Center of Nantong University","place":["Kunshan, Jiangsu, China"]},{"name":"Department of Stroke Center, The First People's Hospital of Kunshan","place":["Kunshan, Jiangsu, China"]},{"name":"Department of Neurology, The First People's Hospital of Kunshan","place":["Kunshan, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yakun","family":"Ren","sequence":"additional","affiliation":[{"name":"Kunshan Clinical Innovation Research Center of Nantong University","place":["Kunshan, Jiangsu, China"]},{"name":"Department of Stroke Center, The First People's Hospital of Kunshan","place":["Kunshan, Jiangsu, China"]},{"name":"Department of Ultrasound, The First People's Hospital of Kunshan","place":["Kunshan, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Shao","sequence":"additional","affiliation":[{"name":"Kunshan Clinical Innovation Research Center of Nantong University","place":["Kunshan, Jiangsu, China"]},{"name":"Department of Stroke Center, The First People's Hospital of Kunshan","place":["Kunshan, Jiangsu, China"]},{"name":"Department of Ultrasound, The First People's Hospital of Kunshan","place":["Kunshan, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1007\/s10072-019-03977-2","article-title":"Posterior circulation ischaemic stroke\u2014a review part I: anatomy, aetiology and clinical presentations","volume":"40","author":"Sparaco","year":"2019","journal-title":"Neurol Sci"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/ana.20204","article-title":"New England medical center posterior circulation registry","volume":"56","author":"Caplan","year":"2004","journal-title":"Ann Neurol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1056\/NEJMoa2206317","article-title":"Trial of endovascular treatment of acute basilar-artery occlusion","volume":"387","author":"Tao","year":"2022","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S1474-4422(21)00376-8","article-title":"Intracranial atherosclerotic stenosis: risk factors, diagnosis, and treatment","volume":"21","author":"Gutierrez","year":"2022","journal-title":"Lancet Neurol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0140-6736(13)62038-3","article-title":"Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial","volume":"383","author":"Derdeyn","year":"2014","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/S1474-4422(19)30149-8","article-title":"Stenting for symptomatic vertebral artery stenosis: a preplanned pooled individual patient data analysis","volume":"18","author":"Markus","year":"2019","journal-title":"Lancet Neurol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ejvs.2022.04.011","article-title":"Editor\u2019s choice \u2013 European Society for Vascular Surgery (ESVS) 2023 clinical practice guidelines on the management of atherosclerotic carotid and vertebral artery disease","volume":"65","author":"Naylor","year":"2023","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1161\/STROKEAHA.123.043633","article-title":"Optimal medical Management of Atherosclerotic Intracranial Stenosis","volume":"55","author":"Wabnitz","year":"2024","journal-title":"Stroke"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1161\/STROKEAHA.123.044270","article-title":"Past, present, and future of intracranial atherosclerosis treatment","volume":"55","author":"De Havenon","year":"2024","journal-title":"Stroke"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jvd5010001","article-title":"Surgical Management of Intracranial Atherosclerotic Disease: current evidence and future directions in stroke prevention","volume":"5","author":"Demir","year":"2026","journal-title":"JVD"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1001609","DOI":"10.3389\/fneur.2022.1001609","article-title":"Recurrent stroke risk in intracranial atherosclerotic disease","volume":"13","author":"Ballout","year":"2022","journal-title":"Front Neurol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1161\/STROKEAHA.120.033152","article-title":"Residual inflammatory risk predicts poor prognosis in acute ischemic stroke or transient ischemic attack patients","volume":"52","author":"Li","year":"2021","journal-title":"Stroke"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1016\/j.jacc.2025.08.047","article-title":"Inflammation and cardiovascular disease: 2025 ACC scientific statement","volume":"87","author":"Mensah","year":"2026","journal-title":"J Am Coll Cardiol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1161\/CIRCRESAHA.115.306656","article-title":"From C-reactive protein to Interleukin-6 to Interleukin-1: moving upstream to identify novel targets for Atheroprotection","volume":"118","author":"Ridker","year":"2016","journal-title":"Circ Res"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"e208016","DOI":"10.1212\/WNL.0000000000208016","article-title":"C-reactive protein, interleukin-6, and vascular recurrence according to stroke subtype: an individual participant data meta-analysis","volume":"102","author":"McCabe","year":"2024","journal-title":"Neurology"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","article-title":"The changing landscape of atherosclerosis","volume":"592","author":"Libby","year":"2021","journal-title":"Nature"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1001\/jamaneurol.2015.3772","article-title":"Effect of hemodynamics on stroke risk in symptomatic atherosclerotic vertebrobasilar occlusive disease","volume":"73","author":"Amin-Hanjani","year":"2016","journal-title":"JAMA Neurol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"11631","DOI":"10.3390\/ijms252111631","article-title":"Understanding endothelial dysfunction and its role in ischemic stroke after the outbreak of recanalization therapies","volume":"25","author":"De La Riva","year":"2024","journal-title":"IJMS"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/s41569-021-00552-1","article-title":"Interplay between inflammation and thrombosis in cardiovascular pathology","volume":"18","author":"Stark","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1161\/ATVBAHA.125.322557","article-title":"Fluid shear stress\u2013regulated vascular remodeling: past, present, and future","volume":"45","author":"Deng","year":"2025","journal-title":"ATVB"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"Von Elm","year":"2007","journal-title":"Lancet"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1159\/000540914","article-title":"Association between bilateral vertebral artery blood flow changes and posterior circulation infarction in patients with severe intracranial stenosis","volume":"54","author":"Yuan","year":"2024","journal-title":"Cerebrovasc Dis"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1161\/CIRCRESAHA.116.308441","article-title":"Stroke caused by atherosclerosis of the major intracranial arteries","volume":"120","author":"Banerjee","year":"2017","journal-title":"Circ Res"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1435004","DOI":"10.3389\/fpubh.2024.1435004","article-title":"Combined impact of elevated C-reactive protein levels and dyslipidemia on stroke: a CHNS prospective cohort study","volume":"12","author":"Lv","year":"2024","journal-title":"Front Public Health"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"207","DOI":"10.5853\/jos.2024.03251","article-title":"Residual inflammatory risk and intracranial atherosclerosis plaque vulnerability: insights from high-resolution magnetic resonance imaging","volume":"27","author":"Yu","year":"2025","journal-title":"J Stroke"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1161\/01.STR.31.8.2011","article-title":"Posterior circulation ischemia: then, now, and tomorrow: The Thomas Willis lecture\u20142000","volume":"31","author":"Caplan","year":"2000","journal-title":"Stroke"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1093\/eurheartj\/ehw024","article-title":"Residual inflammatory risk: addressing the obverse side of the atherosclerosis prevention coin","volume":"37","author":"Ridker","year":"2016","journal-title":"Eur Heart J"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.yjmcc.2007.08.015","article-title":"C-reactive protein decreases endothelial nitric oxide synthase activity via uncoupling","volume":"43","author":"Singh","year":"2007","journal-title":"J Mol Cell Cardiol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/S0140-6736(23)00215-5","article-title":"Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials","volume":"401","author":"Ridker","year":"2023","journal-title":"Lancet"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/nri3345","article-title":"Thrombosis as an intravascular effector of innate immunity","volume":"13","author":"Engelmann","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1186\/s12883-024-03929-0","article-title":"Association between hs-CRP\/HDL-C ratio and three-month unfavorable outcomes in patients with acute ischemic stroke: a second analysis based on a prospective cohort study","volume":"24","author":"Luwen","year":"2024","journal-title":"BMC Neurol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1186\/s10020-024-01025-0","article-title":"The pleiotropic effects of statins: a comprehensive exploration of neurovascular unit modulation and blood\u2013brain barrier protection","volume":"30","author":"Liu","year":"2024","journal-title":"Mol Med"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"e214214","DOI":"10.1212\/WNL.0000000000214214","article-title":"Anti-inflammatory therapies for atherosclerotic stroke prevention","volume":"105","author":"Georgakis","year":"2025","journal-title":"Neurology"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N Engl J Med"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0140-6736(24)00968-1","article-title":"Long-term colchicine for the prevention of vascular recurrent events in non-cardioembolic stroke (CONVINCE): a randomised controlled trial","volume":"404","author":"Kelly","year":"2024","journal-title":"Lancet"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1016\/S0140-6736(21)00520-1","article-title":"IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial","volume":"397","author":"Ridker","year":"2021","journal-title":"Lancet"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1001\/jamacardio.2025.4491","article-title":"Rationale, design, and baseline clinical characteristics of the Ziltivekimab cardiovascular outcomes trial: interleukin-6 inhibition and atherosclerotic event rate reduction","volume":"11","author":"Ridker","year":"2026","journal-title":"JAMA Cardiol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"e038086","DOI":"10.1161\/JAHA.124.038086","article-title":"Exploring the link between C-reactive protein change and stroke risk: insights from a prospective cohort study and genetic evidence","volume":"14","author":"Ling","year":"2025","journal-title":"J Am Heart Assoc"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1829231\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T04:23:09Z","timestamp":1787631789000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1829231\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":40,"alternative-id":["10.3389\/fneur.2026.1829231"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2026.1829231","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"article-number":"1829231"}}